Synthesis of small molecule CDC25 phosphatases inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 23, 2004, Pages 5809-5812

  Contour Galcéra, Marie Odile ^a   Lavergne, Olivier ^a   Brezak, Marie Christine ^a   Ducommun, Bernard ^b   Prévost, Grégoire ^a  

^a ULIS   (France)

^b Institut d'Exploration Fonctionnelle des Genomes   (France)

Author keywords

Antiproliferative agent; CDC25 inhibitor; Dual specificity phosphatases inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; BN 82002; LEAD; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; SMALL MOLECULE TRANSPORT AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION;

CDC25 PHOSPHATASE; HUMANS; PROTEASE INHIBITORS;

EID: 7044229678     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.09.041     Document Type: Article

References (21)

1. A. Kumagai, and W.G. Dunphy Cell 64 1991 903 914
2. U. Strausfeld, J.-C. Labbe, D. Fesquet, J.-C. Cavadore, A. Picard, K. Sadhu, P. Russell, and M. Doree Nature 351 1991 242 245
3. J. Gautier, M.J. Solomon, R.N. Booher, J.F. Bazan, and M.W. Kirschner Cell 67 1991 197 211
4. D. Gasparotto, R. Maestro, S. Piccinin, T. Vukosavljevic, L. Barzan, S. Sulfaro, and M. Boiocchi Cancer Res. 57 1997 2366 2368
5. J. Guo, J. Kleeff, J. Li, J. Ding, J. Hammer, Y. Zhao, T. Giese, M. Korc, M.W. Büchler, and H. Friess Oncogene 23 2004 71 81
6. J.W. Eckstein Invest. New Drugs 18 2000 149 156
7. K.E. Pestell, A.P. Ducruet, P. Wipf, and J.S. Lazo Oncogene 19 2000 6607 6612
8. G.P. Prevost, M.-C. Brezak, F. Goubin, O. Mondesert, M.-O. Galcera, M. Quaranta, F. Alby, O. Lavergne, and B. Ducommun Prog. Cell Cycle Res. 2003 5225 5234
9. A. Mondesert, M. Lemaire, M.-C. Brezak, M.-O. Galcera-Contour, G. Prevost, B. Ducommun, and B. Bugler Curr. Genet. 45 2004 283 288
10. S.W. Ham, H.J. Park, and D.H. Lim Bioorg. Chem. 25 1997 33 36
11. M. Ando, and S. Emoto Bull. Chem. Soc. Jpn. 51 1978 2433 2434
12. Auvin, S.; Chabrier de Lassauniere, P.-E.; Harnett, J.; Pons, D.; Ulibarri, G. WO 0017190, 2000
13. 3)
14. S.W. Kaldor, M.G. Siegel, J.E. Fritz, B.A. Dressman, and P.J. Hahn Tetrahedron Lett. 37 1996 7193 7196
15. Borohydride, polymer supported (on Amberlite® IRA-400), supplier: Aldrich Chemical Company, Inc
16. 4-Benzyloxybenzaldehyde polystyrene HL (200-400 mesh), 2% DVB, supplier Novabiochem
17. Methylisothiocyanate polystyrene HL (200-400 mesh), 2% DVB, supplier Novabiochem
18. Compounds 7a-n: 50 μmol of aldehyde 5 was added to a mixture of amine 6 (60 μmol, 1.2 equiv) and triethylamine (66 μmol, 1.3 equiv), in anhydrous methanol (1 mL) and the resulting mixture was stirred at room temperature for 18 h. Borohydride (100 μmol, 2 equiv) supported on resin were then added and stirring was maintained for 2 additional hours. Compounds 7a-l: 60 μmol (1.2 equiv) of 4-benzyloxybenzaldehyde polystyrene resin was added and the mixture stirred for 18 h at room temperature. Compounds 7m and 7n: 60 μmol (1.2 equiv) of methylisothiocyanate polystyrene resin was added and the mixture stirred for 18 h at room temperature. In both cases, the resins were filtered and washed with MeOH. The solvent was evaporated and compounds 7a-n were obtained as yellow oils
19. Mass spectra were acquired on a single quadrupole electrospray mass spectrometer (Micromass, Platform model) and HPLC retention times were acquired on an HPLC system (HP 1100) equipped with a photodiode array UV detector
20. M.-C. Brezak, M. Quaranta, O. Mondésert, M.-O. Galcera, O. Lavergne, F. Alby, M. Cazales, V. Baldin, C. Thurieau, J. Harnett, C. Lanco, P.G. Kasprzyk, G.P. Prevost, and B. Ducommun Cancer Res. 64 2004 3320 3325
21. K.N. Prasad, J. Edwards-Prasad, and A. Sakamoto Life Sci. 29 1981 1387 1392